Published in J Clin Microbiol on June 12, 2012
Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms. AIDS (2013) 1.23
Molecular and nonmolecular diagnostic methods for invasive fungal infections. Clin Microbiol Rev (2014) 0.99
Improved detection of deeply invasive candidiasis with DNA aptamers specific binding to (1→3)-β-D-glucans from Candida albicans. Eur J Clin Microbiol Infect Dis (2016) 0.79
Cerebrospinal Fluid (1,3)-Beta-d-Glucan Testing Is Useful in Diagnosis of Coccidioidal Meningitis. J Clin Microbiol (2016) 0.75
Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Clin Infect Dis (2010) 5.53
Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis (2005) 5.24
Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Clin Infect Dis (2010) 4.98
Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis (2004) 4.15
Plasma (1-->3)-beta-D-glucan measurement in diagnosis of invasive deep mycosis and fungal febrile episodes. Lancet (1995) 3.64
1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia. Clin Infect Dis (2008) 3.19
Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia. Clin Infect Dis (2011) 2.54
Serologic studies in coccidioidomycosis. Semin Respir Infect (2001) 2.00
Geographic distribution of endemic fungal infections among older persons, United States. Emerg Infect Dis (2011) 1.94
Diagnostic performance of the (1-->3)-beta-D-glucan assay for invasive fungal disease. Clin Infect Dis (2009) 1.70
Innate immunity to the pathogenic fungus Coccidioides posadasii is dependent on Toll-like receptor 2 and Dectin-1. Infect Immun (2005) 1.53
Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol (2010) 1.24
Observations on (1-3)-beta-D-glucan detection as a diagnostic tool in endemic mycosis caused by Histoplasma or Blastomyces. J Med Microbiol (2007) 1.03
Detection of Coccidioides antigenemia following dissociation of immune complexes. Clin Vaccine Immunol (2009) 1.01
Assessment of serum (1->3)-beta-D-glucan concentration as a measure of disease burden in a murine model of invasive pulmonary aspergillosis. Antimicrob Agents Chemother (2007) 1.01
Coccidioides posadasii contains a single 1,3-beta-glucan synthase gene that appears to be essential for growth. Eukaryot Cell (2005) 0.94
Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis. Clin Infect Dis (2011) 0.91
Case records of the Massachusetts General Hospital. Case 35-2009. A 60-year-old male renal-transplant recipient with renal insufficiency, diabetic ketoacidosis, and mental-status changes. N Engl J Med (2009) 0.83
Histoplasmosis as a cause for a positive Fungitell (1 --> 3)-beta-D-glucan test. Med Mycol (2008) 0.82
Evaluation of Coccidioides antigen detection in dogs with coccidioidomycosis. Clin Vaccine Immunol (2012) 0.82
Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans. Clin Infect Dis (2005) 5.24
Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome. Clin Infect Dis (2004) 4.15
Amphotericin B: time for a new "gold standard". Clin Infect Dis (2003) 4.01
Blood (1->3)-beta-D-glucan as a diagnostic test for HIV-related Pneumocystis jirovecii pneumonia. Clin Infect Dis (2011) 2.54
Amplification of coccidioidal DNA in clinical specimens by PCR. J Clin Microbiol (2004) 1.70
Anti-CD20 (rituximab) therapy for anti-IFN-γ autoantibody-associated nontuberculous mycobacterial infection. Blood (2012) 1.68
Comparisons of community-associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MSRA infections in Sacramento, California. J Clin Microbiol (2006) 1.65
The absence of Candida albicans in milk samples of women with clinical symptoms of ductal candidiasis. Breastfeed Med (2009) 1.56
Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting. J Clin Microbiol (2010) 1.24
Test performance of blood beta-glucan for Pneumocystis jirovecii pneumonia in patients with AIDS and respiratory symptoms. AIDS (2013) 1.23
Reactivity of (1-->3)-beta-d-glucan assay with commonly used intravenous antimicrobials. Antimicrob Agents Chemother (2006) 1.22
Efficacy of intravenous liposomal amphotericin B (AmBisome) against coccidioidal meningitis in rabbits. Antimicrob Agents Chemother (2002) 1.22
Quantification of 1,3-beta-D-glucan levels in children: preliminary data for diagnostic use of the beta-glucan assay in a pediatric setting. Clin Vaccine Immunol (2007) 1.20
Molecular analysis of Clostridium difficile strains isolated from 18 cases of recurrent clostridium difficile-associated diarrhea. J Clin Microbiol (2003) 1.19
Expert opinion: what to do when there is Coccidioides exposure in a laboratory. Clin Infect Dis (2009) 1.13
Nosocomial diarrhea: evaluation and treatment of causes other than Clostridium difficile. Clin Infect Dis (2012) 1.11
Spatial and temporal analysis of Clostridium difficile infection in patients at a pediatric hospital in California. Infect Control Hosp Epidemiol (2005) 1.11
Donor-related coccidioidomycosis in organ transplant recipients. Clin Infect Dis (2003) 1.09
Evaluation of Clostridium difficile fecal load and limit of detection during a prospective comparison of two molecular tests, the illumigene C. difficile and Xpert C. difficile/Epi tests. J Clin Microbiol (2012) 1.07
Outcomes in patients tested for Clostridium difficile toxins. Diagn Microbiol Infect Dis (2012) 1.03
Coccidioidomycosis during pregnancy: a review and recommendations for management. Clin Infect Dis (2011) 1.02
In vitro whole-blood analysis of cellular immunity in patients with active coccidioidomycosis by using the antigen preparation T27K. Clin Diagn Lab Immunol (2002) 1.01
Coccidioides niches and habitat parameters in the southwestern United States: a matter of scale. Ann N Y Acad Sci (2007) 1.01
Epidemiologic surveillance of Clostridium difficile diarrhea in a freestanding pediatric hospital and a pediatric hospital at a university medical center. Diagn Microbiol Infect Dis (2006) 0.96
Fluoride excess in coccidioidomycosis patients receiving long-term antifungal therapy: an assessment of currently available triazoles. Antimicrob Agents Chemother (2011) 0.94
Prevalence and association of macrolide-lincosamide-streptogramin B (MLS(B)) resistance with resistance to moxifloxacin in Clostridium difficile. J Antimicrob Chemother (2003) 0.94
Does ampicillin-sulbactam cause false positivity of (1,3)-beta-D-glucan assay? A prospective evaluation of 15 patients without invasive fungal infections. Mycoses (2011) 0.93
Early treatment with fluconazole may abrogate the development of IgG antibodies in coccidioidomycosis. Clin Infect Dis (2011) 0.91
Treatments for hepatitis B. Clin Infect Dis (2004) 0.88
Comparison of susceptibility of fungal isolates to lufenuron and nikkomycin Z alone or in combination with itraconazole. Am J Vet Res (2005) 0.88
Safety, antigenicity, and efficacy of a recombinant coccidioidomycosis vaccine in cynomolgus macaques (Macaca fascicularis). Ann N Y Acad Sci (2007) 0.87
Derivation and validation of a clinical prediction score for isolation of inpatients with suspected pulmonary tuberculosis. Infect Control Hosp Epidemiol (2008) 0.86
A murine model of coccidioidal meningitis. J Infect Dis (2003) 0.86
Diagnostic value of signs and symptoms of mammary candidosis among lactating women. J Hum Lact (2004) 0.86
Clinical, clinicopathologic, and radiographic findings in dogs with coccidioidomycosis: 24 cases (1995-2000). J Am Vet Med Assoc (2003) 0.85
Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden. Diagn Microbiol Infect Dis (2002) 0.85
Hepatic mucormycosis with abscess formation. Diagn Microbiol Infect Dis (2012) 0.85
Polyfunctional T lymphocytes are in the peripheral blood of donors naturally immune to coccidioidomycosis and are not induced by dendritic cells. Infect Immun (2009) 0.85
Characteristics of the protective subcellular coccidioidal T27K vaccine. Ann N Y Acad Sci (2007) 0.84
Injecting drug use and community-associated methicillin-resistant Staphylococcus aureus infection. Diagn Microbiol Infect Dis (2008) 0.83
Beta-glucan for Pneumocystis pneumonia diagnosis in persons with AIDS: authors' reply. AIDS (2013) 0.83
Isolation of non-toxigenic strains of Clostridium difficile from cases of diarrhea among patients hospitalized in hematology/oncology ward. Pol J Microbiol (2004) 0.83
Seroincidence of Coccidioidomycosis during military desert training exercises. J Clin Microbiol (2004) 0.83
Analysis of Clostridium difficile-associated diarrhea among patients hospitalized in tertiary care academic hospital. Diagn Microbiol Infect Dis (2005) 0.83
Preliminary evaluation of whole-blood gamma interferon release for clinical assessment of cellular immunity in patients with active coccidioidomycosis. Clin Diagn Lab Immunol (2005) 0.82
Immunological characterization of bronchoalveolar lavage fluid in patients with acute pulmonary coccidioidomycosis. J Infect Dis (2013) 0.82
The continuing saga of MRSA. J Infect Dis (2008) 0.82
Risk factors for mammary candidosis among lactating women. J Obstet Gynecol Neonatal Nurs (2005) 0.82
Ribosome-associated nucleophosmin 1: increased expression and shuttling activity distinguishes prognostic subtypes in chronic lymphocytic leukaemia. Br J Haematol (2009) 0.81
The mannose receptor mediates the cellular immune response in human coccidioidomycosis. Infect Immun (2005) 0.81
Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein. Eur J Haematol (2014) 0.81
Potentiation of Toll-like receptor-induced cytokine production by (1-->3)-beta-D-glucans: implications for the monocyte activation test. J Endotoxin Res (2007) 0.80
Detecting Candida albicans in human milk. J Clin Microbiol (2003) 0.79
Prevalence of the ermB gene in Clostridium difficile strains isolated at a university teaching hospital from 1987 through 1998. Clin Infect Dis (2005) 0.78
Coccidioidomycosis and other systemic mycoses of marine mammals stranding along the central California, USA coast: 1998-2012. J Wildl Dis (2015) 0.77
Molecular cloning and expression of a cDNA encoding a Coccidioides posadasii 1,2-alpha-mannosidase identified in the coccidioidal T27K vaccine by immunoproteomic methods. Ann N Y Acad Sci (2007) 0.77
Association between serum 25-hydroxyvitamin D level and type of coccidioidal infection. Med Mycol (2012) 0.77
Determination of ribosomal DNA copy number and comparison among strains of Coccidioides. Mycopathologia (2014) 0.77
Seroprevalence of antibodies against Coccidioides immitis in healthy horses. J Am Vet Med Assoc (2005) 0.77
Production of recombinant endotoxin neutralizing protein in Pichia pastoris and methods for its purification. Protein Expr Purif (2002) 0.77
A new method for the treatment of chronic fungal meningitis: continuous infusion into the cerebrospinal fluid for coccidioidal meningitis. Am J Med Sci (2009) 0.76
Serum galactomannan and (1->3)-β-D-glucan assays for patients with multiple myeloma and Waldenstrom's macroglobulinemia. J Clin Microbiol (2011) 0.76
Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid. Chest (2013) 0.75
Revision and return of a coccidioidal skin test reagent. Mycopathologia (2012) 0.75
Treatment of cytomegalovirus retinitis with cytomegalovirus-specific T-lymphocyte infusion. Ophthalmic Surg Lasers Imaging Retina (2015) 0.75
Favorable Outcome in Coccidioides Endophthalmitis-A Combined Medical and Surgical Treatment Approach. Cornea (2017) 0.75
Lymphocytes from chronic lymphocytic leukaemia undergo ABL1-linked amoeboid motility and homotypic interaction as an early adaptive change to ex vivo culture. Exp Hematol Oncol (2014) 0.75
Coccidioides species determination: does sequence analysis agree with restriction fragment length polymorphism? Mycopathologia (2015) 0.75
Cutaneous manifestations of infection in returning travelers. Curr Infect Dis Rep (2014) 0.75
Comparison of Coccidioides immitis serological antibody titres between forms of clinical coccidioidomycosis in horses. Vet J (2005) 0.75
Molecular cloning and expression of a cDNA encoding a Coccidioides posadasii Cu,Zn superoxide dismutase identified by proteomic analysis of the coccidioidal T27K vaccine. Ann N Y Acad Sci (2007) 0.75
Differing transcriptional responses to pulsed or continuous estradiol exposure in human umbilical vein endothelial cells. J Steroid Biochem Mol Biol (2008) 0.75
Molecular cloning, characterization and expression analysis of two beta-N-acetylhexosaminidase homologs of Coccidioides posadasii. Med Mycol (2010) 0.75
Challenges with using estimates when calculating ART need among adults in South Africa. S Afr Med J (2012) 0.75
Teaching neuroimages: fungus in the brain: coccidioidomycosis meningoencephalitis. Neurology (2013) 0.75